KPRX
Price
$2.91
Change
-$0.12 (-3.96%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
9.22M
PRME
Price
$2.42
Change
-$0.24 (-9.06%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
347.93M
40 days until earnings call
Interact to see
Advertisement

KPRX vs PRME

Header iconKPRX vs PRME Comparison
Open Charts KPRX vs PRMEBanner chart's image
Kiora Pharmaceuticals
Price$2.91
Change-$0.12 (-3.96%)
Volume$170
Capitalization9.22M
Prime Medicine
Price$2.42
Change-$0.24 (-9.06%)
Volume$19.36K
Capitalization347.93M
KPRX vs PRME Comparison Chart in %
Loading...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPRX vs. PRME commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPRX is a Hold and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (KPRX: $3.03 vs. PRME: $2.65)
Brand notoriety: KPRX and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPRX: 3% vs. PRME: 106%
Market capitalization -- KPRX: $9.22M vs. PRME: $347.93M
KPRX [@Biotechnology] is valued at $9.22M. PRME’s [@Biotechnology] market capitalization is $347.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPRX’s FA Score shows that 2 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • KPRX’s FA Score: 2 green, 3 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, KPRX is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPRX’s TA Score shows that 2 TA indicator(s) are bullish while PRME’s TA Score has 6 bullish TA indicator(s).

  • KPRX’s TA Score: 2 bullish, 7 bearish.
  • PRME’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRME is a better buy in the short-term than KPRX.

Price Growth

KPRX (@Biotechnology) experienced а +0.33% price change this week, while PRME (@Biotechnology) price change was +47.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

KPRX is expected to report earnings on May 09, 2025.

PRME is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($348M) has a higher market cap than KPRX($9.22M). KPRX YTD gains are higher at: -8.182 vs. PRME (-9.247). KPRX has higher annual earnings (EBITDA): -9.57M vs. PRME (-200M). PRME has more cash in the bank: 144M vs. KPRX (24.1M). KPRX has less debt than PRME: KPRX (159K) vs PRME (121M). PRME has higher revenues than KPRX: PRME (3.85M) vs KPRX (0).
KPRXPRMEKPRX / PRME
Capitalization9.22M348M3%
EBITDA-9.57M-200M5%
Gain YTD-8.182-9.24788%
P/E Ratio3.67N/A-
Revenue03.85M-
Total Cash24.1M144M17%
Total Debt159K121M0%
FUNDAMENTALS RATINGS
KPRX vs PRME: Fundamental Ratings
KPRX
PRME
OUTLOOK RATING
1..100
9424
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6137
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (23) in the Pharmaceuticals Other industry is in the same range as PRME (51) in the null industry. This means that KPRX’s stock grew similarly to PRME’s over the last 12 months.

KPRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as PRME (100) in the null industry. This means that KPRX’s stock grew similarly to PRME’s over the last 12 months.

KPRX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as PRME (98) in the null industry. This means that KPRX’s stock grew similarly to PRME’s over the last 12 months.

PRME's Price Growth Rating (37) in the null industry is in the same range as KPRX (61) in the Pharmaceuticals Other industry. This means that PRME’s stock grew similarly to KPRX’s over the last 12 months.

KPRX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for PRME (100) in the null industry. This means that KPRX’s stock grew significantly faster than PRME’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPRXPRME
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDSX0.280.01
+2.52%
Biodesix
KLIC35.380.45
+1.29%
Kulicke and Soffa Industries
LMFA2.320.03
+1.09%
LM Funding America
MAA147.461.55
+1.06%
Mid-America Apartment Communities
ANAB23.380.14
+0.60%
AnaptysBio

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been loosely correlated with OVID. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KPRX jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
N/A
OVID - KPRX
35%
Loosely correlated
+9.06%
PRME - KPRX
33%
Poorly correlated
+9.50%
AKTX - KPRX
30%
Poorly correlated
+0.86%
MTVA - KPRX
30%
Poorly correlated
+0.10%
TCRT - KPRX
29%
Poorly correlated
+11.31%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+9.50%
CRSP - PRME
63%
Loosely correlated
-0.17%
RXRX - PRME
57%
Loosely correlated
+4.65%
BEAM - PRME
57%
Loosely correlated
+2.27%
CRBU - PRME
53%
Loosely correlated
-4.93%
CCCC - PRME
50%
Loosely correlated
-1.30%
More